DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 164 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $413,007 | -14.3% | 26,256 | -11.5% | 0.00% | – |
| Q4 2023 | $481,841 | +103.7% | 29,670 | +59.4% | 0.00% | – |
| Q3 2023 | $236,571 | -87.8% | 18,613 | -86.5% | 0.00% | -100.0% |
| Q2 2023 | $1,938,925 | +1662.7% | 137,610 | +1073.1% | 0.00% | – |
| Q1 2022 | $110,000 | -4.3% | 11,730 | +4.2% | 0.00% | – |
| Q4 2021 | $115,000 | -72.6% | 11,254 | +55.1% | 0.00% | -100.0% |
| Q4 2020 | $420,000 | +27.3% | 7,258 | -25.3% | 0.00% | 0.0% |
| Q3 2019 | $330,000 | – | 9,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
| Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
| BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
| Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
| ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
| Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
| Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
| Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
| Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |